| 000 | 01855 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513185352.0 | ||
| 264 | 0 | _c19990812 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0749-503X | ||
| 024 | 7 |
_a10.1002/(SICI)1097-0061(19990630)15:9<755::AID-YEA417>3.0.CO;2-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLamb, D C | |
| 245 | 0 | 0 |
_aCharacteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents. _h[electronic resource] |
| 260 |
_bYeast (Chichester, England) _cJun 1999 |
||
| 300 |
_a755-63 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntifungal Agents _xchemistry |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aCandida albicans _xenzymology |
| 650 | 0 | 4 |
_aCarbon Monoxide _xmetabolism |
| 650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xchemistry |
| 650 | 0 | 4 |
_aFormates _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aItraconazole _xchemistry |
| 650 | 0 | 4 |
_aKetoconazole _xchemistry |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aOxidoreductases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRecombinant Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSpectrum Analysis |
| 650 | 0 | 4 | _aSterol 14-Demethylase |
| 650 | 0 | 4 | _aTitrimetry |
| 700 | 1 | _aKelly, D E | |
| 700 | 1 | _aWaterman, M R | |
| 700 | 1 | _aStromstedt, M | |
| 700 | 1 | _aRozman, D | |
| 700 | 1 | _aKelly, S L | |
| 773 | 0 |
_tYeast (Chichester, England) _gvol. 15 _gno. 9 _gp. 755-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1097-0061(19990630)15:9<755::AID-YEA417>3.0.CO;2-8 _zAvailable from publisher's website |
| 999 |
_c10356611 _d10356611 |
||